• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体状态与乳腺癌中DNA倍体的关系。

The relationship of estrogen receptor status to DNA ploidy in breast cancer.

作者信息

Tsuchiya A, Nihei M, Ando Y, Suzuki S, Kimijima I, Abe R

机构信息

Second Department of Surgery, Fukushima Medical College, Japan.

出版信息

Surg Today. 1992;22(2):105-9. doi: 10.1007/BF00311332.

DOI:10.1007/BF00311332
PMID:1498488
Abstract

The relationship of estrogen receptor (ER) status to DNA ploidy was investigated in 121 patients with breast cancer who underwent surgery. Lymph node status was evaluated histologically and ER levels were determined by the dextran-coated charcoal method, with a level of 3 fmol/mg.protein being considered positive. Flow cytometric DNA content was analyzed using paraffin-embedded tissue blocks. Sixty-three percent of the specimens were ER+, while 37 percent were negative. Sixty-one patients (50.4 percent) were diploid and 60 aneuploid. A statistically significant correlation between the ER positivity rate and diploid DNA was found. Higher ER levels were seen in the postmenopausal patients with diploid tumors than in those with aneuploid tumors and there was a significant tendency for ER levels to be higher in the diploid tumors. Nodal status was not correlated with ER positivity or ploidy pattern. The present results indicate that ER levels are correlated with DNA ploidy, and reflect the degree of functional differentiation.

摘要

对121例行手术治疗的乳腺癌患者,研究了雌激素受体(ER)状态与DNA倍体的关系。通过组织学评估淋巴结状态,采用葡聚糖包被活性炭法测定ER水平,以3 fmol/mg蛋白质的水平为阳性。使用石蜡包埋组织块分析流式细胞术DNA含量。63%的标本ER阳性,37%为阴性。61例患者(50.4%)为二倍体,60例为非整倍体。发现ER阳性率与二倍体DNA之间存在统计学显著相关性。绝经后二倍体肿瘤患者的ER水平高于非整倍体肿瘤患者,且二倍体肿瘤中ER水平有显著升高趋势。淋巴结状态与ER阳性或倍体模式无关。目前的结果表明,ER水平与DNA倍体相关,并反映功能分化程度。

相似文献

1
The relationship of estrogen receptor status to DNA ploidy in breast cancer.雌激素受体状态与乳腺癌中DNA倍体的关系。
Surg Today. 1992;22(2):105-9. doi: 10.1007/BF00311332.
2
Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.乳腺癌中类固醇受体异质性与DNA指数的关系:对石蜡包埋肿瘤样本的多参数流式细胞术研究方法
Breast J. 2001 Jul-Aug;7(4):249-59. doi: 10.1046/j.1524-4741.2001.20108.x.
3
DNA ploidy and survival in breast cancer patients.乳腺癌患者的DNA倍体与生存情况
Cytometry. 1987 Mar;8(2):225-34. doi: 10.1002/cyto.990080217.
4
Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Int J Cancer. 1992 Apr 22;51(1):28-33. doi: 10.1002/ijc.2910510106.
5
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.流式细胞术DNA分析及雌激素受体含量在乳腺癌中的预后意义——一项10年生存研究
Breast Cancer Res Treat. 1992;24(2):115-26. doi: 10.1007/BF01961244.
6
Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.原发性乳腺癌中细胞DNA含量、S期分数、激素受体状态与年龄之间的相互关系。对1342例连续检测的肿瘤进行的系列研究。瑞典东南部乳腺癌研究小组。
Acta Oncol. 1992;31(3):283-92. doi: 10.3109/02841869209108174.
7
A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.一种用于石蜡包埋乳腺癌的新型流式细胞术类固醇激素受体检测方法:在单管检测中对类固醇激素受体进行客观定量,并与倍体状态和增殖能力直接相关。
Hum Pathol. 2000 May;31(5):584-92. doi: 10.1053/hp.2000.6700.
8
Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.653名日本腋窝淋巴结阴性乳腺癌女性患者中DNA倍体的预后价值
Int J Clin Oncol. 2001 Aug;6(4):177-82. doi: 10.1007/pl00012103.
9
Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.人类乳腺癌的核DNA含量与预后:一项静态细胞光度学研究。
Breast Cancer Res Treat. 1987;9(2):101-9. doi: 10.1007/BF01807362.
10
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.乳腺癌中DNA倍体和细胞增殖的短期意义:对308例患者预后标志物的多变量分析
J Clin Pathol. 1999 Aug;52(8):604-11. doi: 10.1136/jcp.52.8.604.

本文引用的文献

1
Correlation of primary breast cancer histopathology and estrogen receptor content.
Breast Cancer Res Treat. 1981;1(1):37-41. doi: 10.1007/BF01807890.
2
Steroid hormone receptors and carcinoma of the breast.类固醇激素受体与乳腺癌
Am J Physiol. 1982 Aug;243(2):E99-102. doi: 10.1152/ajpendo.1982.243.2.E99.
3
A prognostic index in primary breast cancer.原发性乳腺癌的预后指数
Br J Cancer. 1982 Mar;45(3):361-6. doi: 10.1038/bjc.1982.62.
4
Two-stage model for carcinogenesis: Epidemiology of breast cancer in females.致癌作用的两阶段模型:女性乳腺癌的流行病学
J Natl Cancer Inst. 1980 Sep;65(3):559-69.
5
Progesterone and estrogen receptors as prognostic variables in breast cancer.孕激素和雌激素受体作为乳腺癌的预后变量
Cancer Res. 1983 Jun;43(6):2985-90.
6
[Relationship between hormone receptors in human breast cancer and nuclear grade].[人类乳腺癌中激素受体与核分级之间的关系]
Nihon Gan Chiryo Gakkai Shi. 1984 Oct 20;19(9):2172-8.
7
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.雌激素受体、孕激素受体与人乳腺癌患者特征之间的相关性
J Clin Oncol. 1984 Oct;2(10):1102-9. doi: 10.1200/JCO.1984.2.10.1102.
8
Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.雌激素和孕激素受体与乳腺癌组织学分化的相关性
Cancer. 1980 Dec 15;46(12 Suppl):2851-8. doi: 10.1002/1097-0142(19801215)46:12+<2851::aid-cncr2820461424>3.0.co;2-k.
9
Improved sensitivity in the measurement of estrogen receptor in human breast cancer.
J Clin Endocrinol Metab. 1973 Dec;37(6):986-9. doi: 10.1210/jcem-37-6-986.
10
Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.
Breast Cancer Res Treat. 1985;6(2):113-21. doi: 10.1007/BF02235742.